Unknown

Dataset Information

Computational study of the resistance shown by the subtype B/HIV-1 protease to currently known inhibitors.


ABSTRACT: Human immunodeficiency virus type 1 protease (HIV-1 PR) is an essential enzyme in the HIV-1 life cycle. As such, this protein represents a major drug target in AIDS therapy, but emerging resistance to antiretroviral inhibitor cocktails, caused by high viral mutation rates, represents a significant challenge in AIDS treatment. Many mutations are not located within the active site or binding pocket, nor they do significantly modify the three-dimensional structural organization of the enzyme; hence, the mechanism(s) by which they alter inhibitor affinity for the protease remains uncertain. In this article, we present an all-atom computational analysis of the dynamic residue-residue coordination between the active site residues and the rest of the protein and of the energetic properties of dif

SUBMITTER: Genoni A 

PROVIDER: S-EPMC2868114 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature